cyproheptadine has been researched along with mefloquine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Peters, W; Robinson, BL | 1 |
| Agrawal, R; Dutta, GP; Jain, SK; Shukla, OP; Tekwani, BL; Tripathi, R | 1 |
1 review(s) available for cyproheptadine and mefloquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for cyproheptadine and mefloquine
| Article | Year |
|---|---|
The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium.
Topics: Animals; Antimalarials; Cyproheptadine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Malaria; Mefloquine; Mice; Penfluridol; Plasmodium falciparum; Verapamil | 1991 |
Haem polymerase as a novel target of antimalarial action of cyproheptadine.
Topics: Animals; Antimalarials; Chloroquine; Cyproheptadine; Disease Models, Animal; Drug Resistance; Enzyme Inhibitors; Hemeproteins; Mefloquine; Mice; Plasmodium yoelii; Quinine; Transferases; Treatment Outcome | 2002 |